{"contentid": 488077, "importid": NaN, "name": "Exec change at Merck, as Mike Nally quits top marketing job", "introduction": "US pharma giant Merck & Co yesterday revealed that Michael Nally, chief marketing officer, Human Health, will leave the company at the end of March, in order to take up a leadership opportunity with another company.", "content": "<p>US pharma giant Merck &amp; Co (NYSE: MRK) yesterday revealed that Michael Nally, chief marketing officer, Human Health, will leave the company at the end of March, in order to take up a leadership opportunity with another company.</p>\n<p>As a result, Merck says that Frank Clyburn, currently chief commercial officer, Human Health, will become president, Human Health and lead all Human Health commercial and marketing for the company.</p>\n<p>&ldquo;As our chief marketing officer, Mike has charted ambitious goals for our human health franchises, and has been instrumental in shaping our strategy and ensuring that Merck is well positioned for a successful future,&rdquo; said Kenneth Frazier, chairman and chief executive, who is scheduled to stepdown from the position at the end of this month.</p>\n<p>Though initially reporting to Mr Frazier, starting on April 1, Mr Clyburn will report to Robert Davis, who will become president of Merck, effective April 1, 2021, at which time the company&rsquo;s operating divisions &ndash; Human Health, Animal Health, Manufacturing, and Merck Research Laboratories &ndash; will begin reporting to him. Mr Davis will become chief executive on July 1, 2021.</p>\n<p>Mr Clyburn became chief commercial officer for Human Health in January 2019. Prior to this role, he was the president of Merck&rsquo;s global oncology business. Mr Clyburn joined Merck in 2008 and has had responsibility for numerous global pharmaceutical franchises, including diabetes, cardiovascular and women&rsquo;s health, as well as leadership of marketing and sales teams.</p>", "date": "2021-03-18 12:03:00", "meta_title": "Exec change at Merck, as Mike Nally quits top marketing job", "meta_keywords": "Merck & Co, Resignation, Michael Nally, Chef marketing officer, Human health, Appointment, Frank Clyburn", "meta_description": "Exec change at Merck, as Mike Nally quits top marketing job", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 1, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-03-18 12:02:05", "updated": "2021-03-18 12:12:10", "access": NaN, "url": "https://www.thepharmaletter.com/article/exec-change-at-merck-as-mike-nally-quits-top-marketing-job", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "merck_large.jpg", "image2id": "merck_small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Pharmaceutical", "therapy area_tag": NaN, "topic_tag": "Boardroom, Management", "geography_tag": "USA", "company_tag": "Merck & Co", "drug_tag": NaN, "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-03-18 12:03:00"}